Analysis of malignant melanoma risk and outcomes in solid organ transplant recipients: Assessment of transplant candidacy and the potential role of checkpoint inhibitors-Reference-Cited by-同舟云学术

Analysis of malignant melanoma risk and outcomes in solid organ transplant recipients: Assessment of transplant candidacy and the potential role of checkpoint inhibitors

Published:2021-03-11 Issue:5 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Zwald Fiona¹^ORCID,Carvajal Richard D.²,Walker John³,Sawinski Deirdre⁴^ORCID,Al‐Adra David⁵^ORCID

Affiliation:

1. Piedmont Transplant Institute Atlanta GA USA

2. Division of Hematology‐Oncology Department of Medicine Columbia University Irving Medical Center New York NY USA

3. Department of Medical Oncology University of Alberta Edmonton AB Canada

4. Kidney Pancreas Transplantation University of Pennsylvania Philadelphia PA USA

5. Department of Surgery University of WisconsinSchool of Medicine and Public Health Madison WI USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14264

Reference28 articles.

1. Preexisting melanoma and hematological malignancies, prognosis and timing to solid organ transplantation: a consensus expert opinion statement;Al‐Adra DP;Am J Transplant,2020

2. Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study

3. Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population

4. The incidence and risk factors of de novo skin cancer in the liver transplant recipients;Esfeh JM;Int J Organ Transplant Med,2012

5. Melanoma in Organ Transplant Recipients: Clinicopathological Features and Outcome in 100 Cases

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapamycin inhibits B16 melanoma cell viability in vitro and in vivo by inducing autophagy and inhibiting the mTOR/p70‑S6k pathway;Oncology Letters;2024-02-02

2. Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference;Transplantation;2021-12-13

3. Outcome of pretransplant melanoma after solid organ transplantation: an observational study;Transplant International;2021-09-29